Share this post on:

Product Name :
CFT-8634

Search keywords :
CFT8634

drugId :
null

Target Vo:
Bromodomain-containing protein 9

Target Vo Short Name :
BRD9

Moa_Name:
Bromodomain-containing protein 9 degraders

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
C4 Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Sarcoma, Synovial

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p38 Antibody (YA696)
RASA1 Antibody
Phospho-PKA RII alpha (Ser99) Antibody: Phospho-PKA RII alpha (Ser99) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 46 kDa, targeting to Phospho-PKA RII alpha (Ser99). It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Pig.

Share this post on:

Author: Betaine hydrochloride